Webster, TXNCT07041099Now EnrollingIRB Ready

Sjögren Clinical Trial in Webster, TX

Access cutting-edge sjögren treatment through this phase 1 clinical trial at a research site in Webster. Study-provided care at no cost to qualified participants.

Sponsored by Cullinan Therapeutics Inc.

Quick Self-Assessment

See if you qualify for this Webster location

Preparing your pre-screening questions…

Expert Care in Webster

Access sjögren specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related sjögren treatment provided free

Apply for This Webster Location

Check if you qualify for this sjögren clinical trial in Webster, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Webster

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Webster site if eligible
  4. 4Begin participation

About This Sjögren Study in Webster

A phase 1b, open-label study of CLN-978 administered subcutaneously in patients with active, moderate to severe Sjogren's Disease.

Sponsor: Cullinan Therapeutics Inc.

Who Can Participate

Inclusion Criteria

Diagnosis of SjD at least 24 weeks prior to Screening Visit and meet the 2016 EULAR / ACR Classification Criteria for SjD at Screening.
Have active moderate to severe disease (i.e., ESSDAI ≥5) at Screening.
Laboratory parameters including the following:
Absolute lymphocyte count (ALC) ≥0.5 × 10\^9/L
Peripheral CD19+ B cell count ≥25 cells/µL
Absolute neutrophil count (ANC) ≥1.0 × 10\^9/L
Hemoglobin (Hgb) ≥8 g/dL
Platelet count ≥75 × 10\^9/L
Total bilirubin ≤1.5 × ULN, except patients with confirmed Gilbert's Syndrome
Aspartate aminotransferase (AST) and Alanine aminotransferase (ALT) ≤2.0 × ULN
Estimated glomerular filtration rate (eGFR) based on the CKD-EPI formula ≥30 mL/min/1.73 m2

Exclusion Criteria

Concomitant rheumatological autoimmune disease
Considered at high risk for thrombosis
Rapidly progressive glomerulonephritis and/or urine protein/creatinine \>3 mg/mg (339 mg/mmol).
Active, severe central nervous system manifestations of SjD.
History of stroke, seizure, dementia, Parkinson's disease, coordination movement disorder, cerebellar diseases, psychosis, paresis, aphasia, and any other neurologic disorder that the Investigator feels would put the patient at undue risk or confound study results.
Evidence of hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), Epstein-Barr virus (EBV), or cytomegalovirus (CMV) infection.
Primary immunodeficiency or history of recurrent infections.
History of splenectomy.
Live or attenuated vaccine within 28 days prior to the Screening Visit or during the Screening Period.
Active, clinically significant bacterial, viral, fungal, mycobacterial, parasitic, or other infection, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, within 14 days prior to Day 1.
Active or latent tuberculosis (TB)

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Webster?

Yes, this clinical trial (NCT07041099) has an active research site in Webster, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Sjögren Treatment Options in Webster, TX

If you're searching for sjögren treatment options in Webster, TX, this clinical trial (NCT07041099) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Webster research site is actively enrolling participants for this phase 1 clinical trial. You'll receive care from experienced sjögren specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all sjögren clinical trials near you to find additional studies recruiting in your area.

More Sjogrens Syndrome Trials in Webster, TX

See all sjogrens syndrome clinical trials recruiting in Webster — not just this study.

Browse Sjogrens Syndrome Trials in Webster →

Browse More Trials by Condition

Sjogrens Syndrome TrialsAll Conditions →

Ready to Join in Webster?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Webster, TX